Total: 670

    Guidelines for identification and management of substance use and substance use disorders in pregnancy

    These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder. They have been develope...

    Ensuring human rights in the provision of contraceptive information and services: guidance and recommendations

    These WHO guidelines provide recommendations for programmes as to how they can ensure that human rights are respected, protected and fulfilled, while services are scaled up to reduce unmet need for contraception. Both health data and international human rights laws and treaties were incorporated into the...

    Guideline: fortification of food-grade salt with iodine for the prevention and control of iodine deficiency disorders

    The proposed guideline aims to help Member States and their partners in their efforts to make informed decisions on the appropriate nutrition actions to achieve the Millennium Development Goals (MDGs), in particular, reduction of child mortality (MDG 4) and improvement of maternal health (MDG 5). It will...

    Guideline: delayed umbilical cord clamping for improved maternal and infant health and nutrition outcomes

    Member States have requested guidance from WHO on the effects of late cord clamping for improving maternal and infant nutrition and health, as a public health strategy in support of their efforts to achieve the Millennium Development Goals, as well as the global targets set in the Comprehensive implement...

    Medical eligibility criteria for contraceptive use

    This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, presents current WHO guidance on the safety of various contraceptive methods for use in the context of spe...

    Comprehensive cervical cancer control: a guide to essential practice

    This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and c...

    Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

    In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...

    Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

    These are the first World Health Organization (WHO) guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar recently published guidance by WHO on the prevention, care and treatment of infection due to the hepatitis C virus (HCV)...

    Systematic screening for active tuberculosis: an operational guide

    Early detection of tuberculosis (TB) is essential to improve health outcomes for people with TB, and to reduce TB transmission more effectively. Systematic screening in high risk groups is a complement to efforts to improve the patient-initiated pathway to TB diagnosis (that is, diagnosing TB among peopl...